Benzoyl Peroxide

Benzoyl Peroxide

SCHEMBL2929886

O=C(OOC(=O)c1ccccc1)c1ccccc1.OO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 1.00
F2 P00734 1/20 1.00
TSHR P16473 6/20 0.64
ALDH1A1 P00352 4/20 0.64
TDP1 Q9NUW8 4/20 0.64
HSD17B10 Q99714 2/20 0.64
TP53 P04637 1/20 0.56
CES2 O00748 2/20 0.55
CES1 P23141 2/20 0.55
DAO P14920 1/20 0.55
NAPRT Q6XQN6 1/20 0.55
KMT2A Q03164 3/20 0.54
MAPT P10636 3/20 0.54
POLB P06746 2/20 0.54
MAPK1 P28482 1/20 0.54
HIF1A Q16665 1/20 0.54
SLC6A2 P23975 1/20 0.54
SLC6A3 Q01959 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoyl Peroxide SCHEMBL9407293 1.00 LMNA (1.00) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL5312311 1.00 LMNA (1.00) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL63 1.00 LMNA (1.00) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL3467853 1.00 LMNA (1.00) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL7546726 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL11134661 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL9463392 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL9496902 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL178097 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1
Benzoyl Peroxide SCHEMBL4745654 0.97 LMNA (0.94) LMNAF2TSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3297775-A1 COMPOSITIONS, DEVICES, SYSTEMS AND METHODS RELATING TO PHOTO- AND THERMAL- OXIDATIVE BLEACHING OF PINK-STAINS Gestalt Sciences Corporation (US) 2018-03-28 EP claimed
US-20230248636-A1 METHODS FOR PREPARATION OF KERATIN FIBER COLOR COATINGS WITH A CARBOXYLIC ACID POLYMER - CDI COMPOSITION HERRLEIN MATHIAS KURT (DE) 2023-08-10 US disclosed
EP-4171494-A1 METHODS FOR PREPARATION OF KERATIN FIBER COLOR COATINGS WITH A CARBOXYLIC ACID POLYMER - CDI COMPOSITION Wella Germany GmbH (DE) 2023-05-03 EP disclosed
WO-2022002986-A1 METHODS FOR PREPARATION OF KERATIN FIBER COLOR COATINGS WITH A CARBOXYLIC ACID POLYMER - CDI COMPOSITION HFC PRESTIGE SERVICE GERMANY GMBH (DE) 2022-01-06 WO disclosed
CN-105985603-B Resin composition for supercapacitor electrode, slurry, electrode, and supercapacitor 奇美实业股份有限公司 2019-04-02 CN disclosed
CN-105985481-B Resin composition for supercapacitor electrode, slurry, electrode, and supercapacitor 奇美实业股份有限公司 2018-06-26 CN disclosed
CN-107708853-A Encapsulating 恩盖普有限公司 2018-02-16 CN disclosed
CN-105985603-A Resin composition for supercapacitor electrode, slurry, electrode, and supercapacitor 奇美实业股份有限公司 2016-10-05 CN disclosed
CN-105985481-A Resin composition for supercapacitor electrode, slurry, electrode, and supercapacitor 奇美实业股份有限公司 2016-10-05 CN disclosed
CN-104629064-A Method for rapidly preparing double-layer hydrogel by adopting laser-induced oil-water two-phase continuous front-end polymerization NANJING UNIVERSITY OF TECHNOLOGY 2015-05-20 CN disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0363460-B1 EPOXY-AMINE COMPOSITIONS EMPLOYING UNSATURATED IMIDES LOCTITE CORP (US) 1993-12-22 EP disclosed
US-5210103-A Coblowing agents are water and silicone oil, polyurethane, no halogenated hydrocarbon is used BASF CORPORATION (US) 1993-05-11 US disclosed
EP-0363460-A1 EPOXY-AMINE COMPOSITIONS EMPLOYING UNSATURATED IMIDES. LOCTITE CORP (US) 1990-04-18 EP disclosed
US-4886842-A PHOTOCURABLE BLEND; HEAT-RESISTANT ADHESIVES FOR ELECTRICAL COMPONENTS LOCTITE CORPORATION (US) 1989-12-12 US disclosed
WO-1989008122-A1 EPOXY-AMINE COMPOSITIONS EMPLOYING UNSATURATED IMIDES LOCTITE CORPORATION (US) 1989-09-08 WO disclosed
US-4837295-A IMPROVED INITIAL ADHESION AND THERMAL SHOCK RESISTANCE LOCTITE CORPORATION (US) 1989-06-06 US disclosed
EP-0000247-B1 WATER-ABSORBENT STARCH COPOLYMERISATES AND METHOD FOR THEIR PREPARATION. A.E. STALEY MANUFACTURING COMPANY (US) 1982-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248636-A1 METHODS FOR PREPARATION OF KERATIN FIBER COLOR COATINGS WITH A CARBOXYLIC ACID POLYMER - CDI COMPOSITION KRT18, CRYAA, DCX LMNA 594/4885F2 1143/4885TSHR 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.